Biological evaluation of isoflavonoids from Genista halacsyi using estrogen-target cells: Activities of glucosides compared to aglycones.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 26 09 2018
accepted: 19 12 2018
entrez: 9 1 2019
pubmed: 9 1 2019
medline: 19 10 2019
Statut: epublish

Résumé

The purpose of this study was to evaluate the response of estrogen target cells to a series of isoflavone glucosides and aglycones from Genista halacsyi Heldr. The methanolic extract of aerial parts of this plant was processed using fast centrifugal partition chromatography, resulting in isolation of four archetypal isoflavones (genistein, daidzein, isoprunetin, 8-C-β-D-glucopyranosyl-genistein) and ten derivatives thereof. 7-O-β-D-glucopyranosyl-genistein and 7,4΄-di-O-β-D-glucopyranosyl-genistein were among the most abundant constituents of the isolate. All fourteen, except genistein, displayed low binding affinity for estrogen receptors (ER). Models of binding to ERα could account for the low binding affinity of monoglucosides. Genistein and its glucosides displayed full efficacy in inducing alkaline phosphatase (AlkP) in Ishikawa cells, proliferation of MCF-7 cells and ER-dependent gene expression in reporter cells at low concentrations (around 0.3 μM). ICI182,780 fully antagonized these effects. The AlkP-inducing efficacy of the fourteen isoflavonoids was more strongly correlated with their transcriptional efficacy through ERα. O-monoglucosides displayed higher area under the dose-response curve (AUC) of AlkP response relative to the AUC of ERα-transcriptional response compared to the respective aglycones. In addition, 7-O-β-D-glucopyranosyl-genistein and 7,4΄-di-O-β-D-glucopyranosyl-genistein displayed estradiol-like efficacy in promoting differentiation of MC3T3-E1 cells to osteoblasts, while genistein was not convincingly effective in this respect. Moreover, 7,4΄-di-O-β-D-glucopyranosyl-genistein suppressed lipopolysaccharide-induced tumor necrosis factor mRNA expression in RAW 264.7 cells, while 7-O-β-D-glucopyranosyl-genistein was not convincingly effective and genistein was ineffective. However, genistein and its O-glucosides were ineffective in inhibiting differentiation of RAW 264.7 cells to osteoclasts and in protecting glutamate-challenged HT22 hippocampal neurons from oxidative stress-induced cell death. These findings suggest that 7-O-β-D-glucopyranosyl-genistein and 7,4΄-di-O-β-D-glucopyranosyl-genistein display higher estrogen-like and/or anti-inflammatory activity compared to the aglycone. The possibility of using preparations rich in O-β-D-glucopyranosides of genistein to substitute for low-dose estrogen in formulations for menopausal symptoms is discussed.

Identifiants

pubmed: 30620769
doi: 10.1371/journal.pone.0210247
pii: PONE-D-18-28062
pmc: PMC6324813
doi:

Substances chimiques

Estrogens 0
Flavonoids 0
Glucosides 0
Plant Extracts 0
Receptors, Estrogen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0210247

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Biol Pharm Bull. 2001 Apr;24(4):351-6
pubmed: 11305594
J Nat Med. 2011 Jan;65(1):1-8
pubmed: 20658198
Bioorg Med Chem. 2012 May 1;20(9):2962-70
pubmed: 22464681
Structure. 2004 Dec;12(12):2197-207
pubmed: 15576033
Drug Metab Dispos. 2008 Aug;36(8):1485-95
pubmed: 18443032
Clin Interv Aging. 2008;3(4):711-8
pubmed: 19281063
In Vitro Cell Dev Biol Anim. 2006 Jul-Aug;42(7):182-8
pubmed: 16948499
J Clin Endocrinol Metab. 2015 Nov;100(11):3975-4011
pubmed: 26444994
Endocrinology. 2006 Oct;147(10):4831-42
pubmed: 16809442
Phytochemistry. 2016 Oct;130:170-81
pubmed: 27179684
Am J Clin Nutr. 2002 Aug;76(2):447-53
pubmed: 12145021
J Steroid Biochem Mol Biol. 2009 Nov;117(4-5):159-67
pubmed: 19772920
Eur J Nutr. 2003 Jan;42(1):29-42
pubmed: 12594539
FEBS Lett. 2009 Aug 6;583(15):2469-73
pubmed: 19577566
Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1566-71
pubmed: 14745018
J Neurochem. 2005 Nov;95(3):745-55
pubmed: 16248886
Obstet Gynecol. 2014 Dec;124(6):1147-56
pubmed: 25415166
J Cell Physiol. 2012 Oct;227(10):3434-45
pubmed: 22213181
J Bone Miner Res. 1992 Jun;7(6):683-92
pubmed: 1414487
J Cell Biochem. 2012 Jan;113(1):247-59
pubmed: 21898547
Planta Med. 2006 May;72(6):488-93
pubmed: 16773531
J Am Chem Soc. 2007 Jul 11;129(27):8443-57
pubmed: 17569534
Biochem Biophys Res Commun. 2010 Oct 22;401(3):356-62
pubmed: 20851107
J Agric Food Chem. 1999 Jan;47(1):56-60
pubmed: 10563849
J Cell Biochem. 2005 May 15;95(2):302-12
pubmed: 15778979
Mol Nutr Food Res. 2009 Sep;53 Suppl 2:S266-309
pubmed: 19774555
J Chromatogr A. 2006 Apr 21;1112(1-2):181-94
pubmed: 16269151
Am J Clin Nutr. 2008 May;87(5):1314-23
pubmed: 18469255
J Med Chem. 2006 Jan 26;49(2):534-53
pubmed: 16420040
Assay Drug Dev Technol. 2012 Feb;10(1):88-96
pubmed: 22066911
Brain Res. 2007 Oct 10;1173:117-25
pubmed: 17765210
Biochimie. 2012 Dec;94(12):2514-22
pubmed: 22796380
Breast Cancer Res Treat. 2003 Jul;80(1):1-13
pubmed: 12889594
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):19012-7
pubmed: 19022902
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jan 25;784(1):137-44
pubmed: 12504192
Nat Chem Biol. 2013 Nov;9(11):708-14
pubmed: 24013279
Biochem Pharmacol. 2005 Dec 19;71(1-2):136-43
pubmed: 16288994
In Vitro Cell Dev Biol Anim. 1994 Feb;30A(2):115-9
pubmed: 8012653
FASEB J. 2013 Nov;27(11):4406-18
pubmed: 23882126
J Endocrinol. 2014 Jan 27;220(3):207-18
pubmed: 24323913
Appl Microbiol Biotechnol. 2013 Feb;97(4):1489-500
pubmed: 23318837
Chem Biol. 2004 Mar;11(3):397-406
pubmed: 15123269
Curr Top Med Chem. 2001 Dec;1(6):497-506
pubmed: 11895126
J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):87-94
pubmed: 18809497
Arch Biochem Biophys. 2000 Dec 15;384(2):391-7
pubmed: 11368329
Nature. 1997 Oct 16;389(6652):753-8
pubmed: 9338790
Toxicology. 2004 Mar 1;196(1-2):137-45
pubmed: 15036763
EMBO Rep. 2007 Jun;8(6):563-8
pubmed: 17468738
Biol Pharm Bull. 2008 Aug;31(8):1621-5
pubmed: 18670101
J Pharmacol Exp Ther. 2007 Aug;322(2):829-35
pubmed: 17495124
Bioorg Med Chem. 2011 Jan 1;19(1):339-51
pubmed: 21129978
J Clin Invest. 1999 Aug;104(4):503-13
pubmed: 10449442
J Nutr. 2000 Jul;130(7):1695-9
pubmed: 10867038
Anal Biochem. 2004 Jun 1;329(1):77-84
pubmed: 15136169
J Steroid Biochem Mol Biol. 2016 Apr;158:138-148
pubmed: 26706281
J Nutr. 2002 Sep;132(9):2587-92
pubmed: 12221213
J Steroid Biochem Mol Biol. 2007 May;104(3-5):228-36
pubmed: 17451940
Endocrinology. 1998 Oct;139(10):4252-63
pubmed: 9751507
Anal Bioanal Chem. 2014 Sep;406(24):6007-20
pubmed: 25103528
Food Funct. 2011 May;2(5):235-44
pubmed: 21779561
Int J Mol Med. 2014 Jan;33(1):178-84
pubmed: 24248634
J Steroid Biochem Mol Biol. 2014 Jan;139:225-36
pubmed: 23270754
J Obstet Gynaecol. 2015;35(8):783-7
pubmed: 25710207
J Med Chem. 2010 Aug 26;53(16):6153-63
pubmed: 20669983
EMBO J. 1999 Sep 1;18(17):4608-18
pubmed: 10469641
Int J Mol Sci. 2014 Jun 12;15(6):10605-21
pubmed: 24927148
J Steroid Biochem Mol Biol. 1993 May;45(5):399-405
pubmed: 8499347
Pharmacol Rev. 2016 Oct;68(4):1026-1073
pubmed: 27677719
J Med Chem. 2007 Jan 25;50(2):241-53
pubmed: 17228866
PLoS One. 2012;7(12):e53101
pubmed: 23300870

Auteurs

Nikolas Fokialakis (N)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.

Xanthippi Alexi (X)

Molecular Endocrinology Program, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece.

Nektarios Aligiannis (N)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.

Athina Boulaka (A)

Molecular Endocrinology Program, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece.

Aggeliki K Meligova (AK)

Molecular Endocrinology Program, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece.

George Lambrinidis (G)

Division of Pharmaceutical Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.

Eleftherios Kalpoutzakis (E)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.

Harris Pratsinis (H)

Laboratory of Cell Proliferation and Ageing, Institute of Biosciences & Applications, NCSR "Demokritos", Athens, Greece.

Antigoni Cheilari (A)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.

Dimitra J Mitsiou (DJ)

Molecular Endocrinology Program, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece.

Sofia Mitakou (S)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.

Michael N Alexis (MN)

Molecular Endocrinology Program, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH